Encompass Health Corporation (BMV:EHC)
Mexico · Delayed Price · Currency is MXN | Market Cap | 212.75B -2.5% |
| Revenue (ttm) | 108.44B +9.5% |
| Net Income | 10.82B +18.8% |
| EPS | 107.17 +19.9% |
| Shares Out | n/a |
| PE Ratio | 19.66 |
| Forward PE | 19.38 |
| Dividend | 13.65 (0.71%) |
| Ex-Dividend Date | Jul 1, 2026 |
| Volume | 29 |
| Open | 1,920.00 |
| Previous Close | n/a |
| Day's Range | 1,920.00 - 1,920.00 |
| 52-Week Range | 1,866.00 - 1,935.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About Encompass Health
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary cond... [Read more]
Financial Performance
In 2025, Encompass Health's revenue was $5.94 billion, an increase of 10.46% compared to the previous year's $5.37 billion. Earnings were $564.70 million, an increase of 24.69%.
Financial numbers in USD Financial StatementsNews
Encompass Health prices private offering of additional 5.875% senior notes due 2034
BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of an additional $100 million in aggregate principal amount of its ...
Encompass Health announces launch of private offering of 5.875% senior notes due 2034
BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of an additional $100 million in aggregate principal amount of 5....
Encompass Health price target raised to $140 from $125 at TD Cowen
TD Cowen raised the firm’s price target on Encompass Health (EHC) to $140 from $125 and keeps a Buy rating on the shares. The firm updated its model following Q2…
Encompass Health price target raised to $150 from $140 at Truist
Truist analyst David MacDonald raised the firm’s price target on Encompass Health (EHC) to $150 from $140 and keeps a Buy rating on the shares. Encompass Health delivered a strong…
Encompass Health price target raised to $150 from $130 at Raymond James
Raymond James raised the firm’s price target on Encompass Health (EHC) to $150 from $130 and keeps a Strong Buy rating on the shares.
Encompass Health price target raised to $155 from $150 at UBS
UBS raised the firm’s price target on Encompass Health (EHC) to $155 from $150 and keeps a Buy rating on the shares.
Encompass Health Earnings Call Transcript: Q2 2026
Q2 2026 saw 9.6% revenue growth and 9.2% adjusted EBITDA growth, prompting a guidance raise for the year. High-acuity patient volumes and strong capacity expansion drove results, while workforce initiatives reduced turnover and premium labor costs.
Encompass Health Earnings release: Q2 2026
Encompass Health released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Encompass Health Slides: Q2 2026
Encompass Health has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
Encompass Health Quarterly report: Q2 2026
Encompass Health has published its Q2 2026 quarterly earnings report on August 6, 2026.
Encompass Health price target raised to $144 from $140 at Barclays
Barclays raised the firm’s price target on Encompass Health (EHC) to $144 from $140 and keeps an Overweight rating on the shares. The firm views the Q2 report as strong.
Encompass Health reports Q2 adjusted EPS $1.55, consensus $1.48
Reports Q2 revenue $1.6B, consensus $1.57B. “We are very pleased with our performance for the second quarter, as revenue increased 9.6% and Adjusted EBITDA grew 9.2%,” said Mark Tarr, President…
Encompass Health raises FY26 adjusted EPS view to $6.02-$6.25 from $5.89-$6.11
Raises FY26 revenue view to $6.41B-$6.49B from $6.375B-$6.47B, consensus $6.42B. Raises FY26 adjusted EBITDA view to $1.365B-$1.395B from $1.35B-$1.38B.
Encompass Health reports results for second quarter 2026
Increases full-year guidance Announces increase in common stock repurchase authorization BIRMINGHAM, Ala., Aug. 5, 2026 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and ...
Encompass Health increases and declares dividend on common stock
Encompass Health (EHC) approved an increase of 2c in the company’s quarterly dividend and declared a quarterly cash dividend on its common stock of 21c per share, payable on Oct.
Encompass Health increases and declares dividend on common stock
BIRMINGHAM, Ala., July 23, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced that its board of directors approved an increase of $0.02 in the Company's quarterly dividend and dec...
Encompass Health announces date of 2026 second quarter earnings call
BIRMINGHAM, Ala., July 9, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its second quarter ended June 30, 2026, after the market closes on Wednesda...
Eastside Rehabilitation Hospital now open in Georgia
The 40-bed inpatient rehabilitation hospital is a joint venture between Encompass Health and Piedmont. BIRMINGHAM, Ala.
Encompass Health to build 36-bed rehabilitation hospital in West Virginia
Encompass Health (EHC) announced plans to build a freestanding, 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia. The hospital will be an expanded relocation of Encompass Health’s...
Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia
BIRMINGHAM, Ala. and BRIDGEPORT, W.Va.
Encompass Health initiated with a Buy at TD Cowen
TD Cowen initiated coverage of Encompass Health (EHC) with a Buy rating and $125 price target The firm says that in an under-supplied inpatient rehab industry, Encompass is “successfully executing…
Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today issued notice for redemption of $400 million of the outstanding principal balance of its 4.500% senior notes due...
Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering
BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of $500 million in aggregate principal amount of 5.875% senior notes...
Encompass Health announces private offering of senior notes
BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of $500 million in aggregate principal amount of senior notes matu...